Published in Hum Mutat on August 01, 2003
The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. Oral Oncol (2006) 1.20
Integrated analysis of oral tongue squamous cell carcinoma identifies key variants and pathways linked to risk habits, HPV, clinical parameters and tumor recurrence. F1000Res (2015) 0.76
Spindle multipolarity is prevented by centrosomal clustering. Science (2005) 3.10
Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck (2007) 2.49
Fluorogen-activating single-chain antibodies for imaging cell surface proteins. Nat Biotechnol (2007) 2.45
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: sources of sample bias. Clin Chem (2007) 2.23
Somatic mutation and gain of copy number of PIK3CA in human breast cancer. Breast Cancer Res (2005) 2.20
TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res (2012) 1.98
Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer (2009) 1.98
Resolution of anaphase bridges in cancer cells. Chromosoma (2004) 1.72
Drug Repurposing from an Academic Perspective. Drug Discov Today Ther Strateg (2011) 1.68
Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells. Cancer Res (2006) 1.60
Feature Selection for Classification of SELDI-TOF-MS Proteomic Profiles. Appl Bioinformatics (2005) 1.56
Uncommon mutation, but common amplifications, of the PIK3CA gene in thyroid tumors. J Clin Endocrinol Metab (2005) 1.51
Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer (2006) 1.49
Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle Nerve (2010) 1.48
A stochastic model for cancer stem cell origin in metastatic colon cancer. Cancer Res (2008) 1.48
High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci U S A (2002) 1.46
Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma. Hum Pathol (2006) 1.41
Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. Eur J Cancer (2005) 1.36
Detection and quantification of beta2AR internalization in living cells using FAP-based biosensor technology. J Biomol Screen (2010) 1.34
Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2. Proc Natl Acad Sci U S A (2004) 1.21
The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. Oral Oncol (2006) 1.20
Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis (2006) 1.19
Fluorogen-activating proteins as biosensors of cell-surface proteins in living cells. Cytometry A (2010) 1.17
Pharmacological rescue of the mutant cystic fibrosis transmembrane conductance regulator (CFTR) detected by use of a novel fluorescence platform. Mol Med (2012) 1.15
Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma. Genes Chromosomes Cancer (2007) 1.11
Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. J Neurochem (2011) 1.10
Chemosensitization of head and neck cancer cells by PUMA. Mol Cancer Ther (2007) 1.09
Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodies. Lab Invest (2005) 1.06
Knowledge about human papillomavirus and the HPV vaccine--a survey of the general population. Infect Agent Cancer (2009) 1.06
Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature. Oral Oncol (2007) 1.02
Comparisons of high-risk cervical HPV infections in Caribbean and US populations. Infect Agent Cancer (2009) 1.01
Chondromyxoid fibroma of rib with a novel chromosomal translocation: a report of four additional cases at unusual sites. Diagn Pathol (2007) 0.99
Polymorphisms in DNA damage response genes and head and neck cancer risk. Biomarkers (2010) 0.98
Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer (2004) 0.97
Cigarette smoke induces anaphase bridges and genomic imbalances in normal cells. Mutat Res (2004) 0.97
Lysine 63-linked polyubiquitination is required for EGF receptor degradation. Proc Natl Acad Sci U S A (2013) 0.96
Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer. Mol Cell Proteomics (2011) 0.95
The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients. Acta Neuropathol (2012) 0.95
The p53-PUMA axis suppresses iPSC generation. Nat Commun (2013) 0.94
RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans. Prostate (2008) 0.93
Relationship between FRA11F and 11q13 gene amplification in oral cancer. Genes Chromosomes Cancer (2007) 0.93
Fluorogen activating proteins in flow cytometry for the study of surface molecules and receptors. Methods (2012) 0.92
Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14). Hum Pathol (2004) 0.92
Determining the subcellular location of new proteins from microscope images using local features. Bioinformatics (2013) 0.91
pNfH is a promising biomarker for ALS. Amyotroph Lateral Scler Frontotemporal Degener (2012) 0.91
Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation. BMC Cancer (2009) 0.89
Chromosomal fragility in patients with triple A syndrome. Am J Med Genet A (2003) 0.88
Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines. Int J Cancer (2014) 0.88
Detection and assignment of mutations and minihaplotypes in human DNA using peptide mass signature genotyping (PMSG): application to the human RDS/peripherin gene. Genome Res (2003) 0.86
DLC1 is unlikely to be a primary target for deletions on chromosome arm 8p22 in head and neck squamous cell carcinoma. Cancer Lett (2004) 0.86
The occurrence of chromosome segregational defects is an intrinsic and heritable property of oral squamous cell carcinoma cell lines. Cancer Genet Cytogenet (2004) 0.85
Fluorescence immunophenotypic and interphase cytogenetic characterization of nodal lymphoplasmacytic lymphoma. Am J Surg Pathol (2008) 0.84
Serum proteomics using mass spectrometry. Methods Mol Biol (2009) 0.84
Generation of a bioactive neuropeptide in a cell-free system. Anal Biochem (2003) 0.83
Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer. Cancer Epidemiol Biomarkers Prev (2009) 0.83
Novel Death Defying Domain in Met entraps the active site of caspase-3 and blocks apoptosis in hepatocytes. Hepatology (2014) 0.82
Splenic small B-cell lymphoma with IGH/BCL3 translocation. Hum Pathol (2006) 0.82
Defining the borders of splenic marginal zone lymphoma: a multiparameter study. Hum Pathol (2009) 0.81
Chromosomal instability and marker chromosome evolution in oral squamous cell carcinoma. Genes Chromosomes Cancer (2004) 0.81
Serum proteomic patterns as a predictor of severity in acute pancreatitis. Pancreatology (2007) 0.80
Myeloperoxidase-dependent oxidation of etoposide in human myeloid progenitor CD34+ cells. Mol Pharmacol (2010) 0.80
Evaluation of a 4-protein serum biomarker panel-biglycan, annexin-A6, myeloperoxidase, and protein S100-A9 (B-AMP)-for the detection of esophageal adenocarcinoma. Cancer (2014) 0.80
Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy. Arthritis Res Ther (2005) 0.79
Relative quantitation of proteins in expressed prostatic secretion with a stable isotope labeled secretome standard. J Proteome Res (2011) 0.78
Detection and assignment of CYP21 mutations using peptide mass signature genotyping. Mol Genet Metab (2004) 0.78
Upregulation of the ATR-CHEK1 pathway in oral squamous cell carcinomas. Genes Chromosomes Cancer (2013) 0.77
Cell cycle dependence of protein subcellular location inferred from static, asynchronous images. Conf Proc IEEE Eng Med Biol Soc (2009) 0.77
Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss. Genes Chromosomes Cancer (2013) 0.77
Carbonic anhydrase I is recognized by an SOD1 antibody upon biotinylation of human spinal cord extracts. Int J Mol Sci (2010) 0.77
Deletion 6q is not a characteristic marker of nodal lymphoplasmacytic lymphoma. Cancer Genet Cytogenet (2005) 0.77
Correlation of Classic and Molecular Cytogenetic Alterations in Soft-Tissue Sarcomas: Analysis of 46 Tumors With Emphasis on Adipocytic Tumors and Synovial Sarcoma. Appl Immunohistochem Mol Morphol (2016) 0.76
Longitudinal bone marrow evaluations for myelodysplasia in patients with myeloma before and after treatment with lenalidomide. Leuk Lymphoma (2013) 0.75
Janet Davison Rowley, M.D. (1925–2013). Am J Hum Genet (2014) 0.75
Integrated Multifunctional Electrochemistry Microchip for Highly Efficient Capture, Release, Lysis and Analysis of Circulating Tumor Cells. Anal Chem (2017) 0.75
Mitochondrial DNA diversity of Monopterus albus from the Sichuan Basin of China. Biochem Genet (2008) 0.75
Rifampicin-induced antineutrophil cytoplasmic antibody-positive vasculitis: a case report and review of the literature. Int J Clin Pharmacol Ther (2016) 0.75
The Genomic Landscape of PAX5, IKZF1, and CDKN2A/B Alterations in B-Cell Precursor Acute Lymphoblastic Leukemia. Cytogenet Genome Res (2017) 0.75
Detection of cystic fibrosis mutations by peptide mass signature genotyping. Clin Chem (2003) 0.75